Paragon 28,

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Paragon 28, and buy or sell other stocks, ETFs, and their options commission-free!

About FNA

Paragon 28, Inc. engages in operation of an orthopedic foot and ankle company. Its products include bone graft harvest system, bone marrow aspirate kits, and soft tissue fixation system. 

CEO
Albert DaCosta
CEOAlbert DaCosta
Employees
525
Employees525
Headquarters
Englewood, Colorado
HeadquartersEnglewood, Colorado
Founded
2010
Founded2010
Employees
525
Employees525

FNA Key Statistics

Market cap
1.10B
Market cap1.10B
Price-Earnings ratio
-19.95
Price-Earnings ratio-19.95
Dividend yield
Dividend yield
Average volume
4.86M
Average volume4.86M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$13.13
52 Week high$13.13
52 Week low
$4.65
52 Week low$4.65

Stock Snapshot

As of today, Paragon 28,(FNA) shares are valued at $13.09. The company's market cap stands at 1.1B, with a P/E ratio of -19.95.

On 2026-02-04, Paragon 28,(FNA) shares started trading at —, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 4.86M.

The stock's 52-week range extends from a low of $4.65 to a high of $13.13.

The stock's 52-week range extends from a low of $4.65 to a high of $13.13.

People also own

Based on the portfolios of people who own FNA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.